Lite Strategy, Inc. Sales Revenue, Services, Net (Deprecated 2018-01-31)
Lite Strategy, Inc. (LITS) reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $1.62 million for the 12-month period ending 2018-06-30, per its 10-K filed 2018-08-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesNet · last filed 2018-08-30
- Lite Strategy, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $548.00K, a 22.05% increase year-over-year.
- Lite Strategy, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $433.00K, a 40.36% decline year-over-year.
- Lite Strategy, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $358.00K, a 265.31% increase year-over-year.
- Lite Strategy, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $283.00K, a 74.18% decline year-over-year.
- Lite Strategy, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2018 was $1.62M, a 31.53% decline from fiscal 2017.
- Lite Strategy, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2017 was $2.37M.
| Period end | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-06-30 | $548.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-30 | $981.00K derived: sum of 2 quarters · filed 2018-08-30 | $1.34M derived: sum of 3 quarters · filed 2018-08-30 | $1.62M 10-K · filed 2018-08-30 |
| 2018-03-31 | $433.00K 10-Q · filed 2018-05-09 | $791.00K derived: sum of 2 quarters · filed 2018-05-09 | $1.07M 10-Q · filed 2018-05-09 | $1.52M derived: sum of 4 quarters · filed 2018-08-30 |
| 2017-12-31 | $358.00K 10-Q · filed 2018-02-08 | $641.00K 10-Q · filed 2018-02-08 | $1.09M derived: sum of 3 quarters · filed 2018-08-30 | $1.82M derived: sum of 4 quarters · filed 2018-08-30 |
| 2017-09-30 | $283.00K 10-Q · filed 2017-11-08 | $732.00K derived: sum of 2 quarters · filed 2018-08-30 | $1.46M derived: sum of 3 quarters · filed 2018-08-30 | $1.56M derived: sum of 4 quarters · filed 2018-08-30 |
| 2017-06-30 | $449.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-30 | $1.18M derived: sum of 2 quarters · filed 2018-08-30 | $1.27M derived: sum of 3 quarters · filed 2018-08-30 | $2.37M 10-K · filed 2018-08-30 |
| 2017-03-31 | $726.00K 10-Q · filed 2018-05-09 | $824.00K derived: sum of 2 quarters · filed 2018-05-09 | $1.92M 10-Q · filed 2018-05-09 | |
| 2016-12-31 | $98.00K 10-Q · filed 2018-02-08 | $1.19M 10-Q · filed 2018-02-08 | ||
| 2016-09-30 | $1.10M 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |